<?xml version="1.0" encoding="UTF-8"?><protocol_summary><protocol><id>14867</id><no>PUMA-ALI-4201-NCT06095505</no><status>Open</status><title>A PHASE 2 STUDY OF ALISERTIB IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER</title><nct_id>NCT06095505</nct_id><sponsor_type>Industrial</sponsor_type><age_group>Adult</age_group><treatment_type>Treatment</treatment_type><phase>II</phase><disease_site>Other</disease_site><PI>Liu, Stephen</PI><institution>Georgetown University Medical Center : Matt Hayhurst; Lombardi Comprehensive Cancer Center : Matt Hayhurst; Medstar Franklin Square Medical Center; Medstar Washington Hospital Center</institution><oncology_group>Thoracic/CNS/H&amp;N/Thyroid<DOWG_name>Oncology Group</DOWG_name></oncology_group><management_group>Lombardi Comprehensive Cancer Center (LCCC); MHRI Oncology Baltimore; MHRI Washington Cancer Institute; Oncology PFS</management_group><item><contact_id>16691</contact_id><item_description>Matt Hayhurst</item_description><js_safe_str>Matt Hayhurst</js_safe_str><email>mh2340@georgetown.edu</email></item></protocol><sipVersion>2026.1.0 Build 16</sipVersion><copyright> &lt;a href="https://advarra.com" target="_blank"&gt;&amp;copy; 2026 Advarra, Inc.&lt;/a&gt; </copyright></protocol_summary>